Manhattan Pharmaceuticals Inc - Current report filing (8-K)
January 03 2008 - 1:56PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): December 27, 2007
Manhattan
Pharmaceuticals, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-32639
|
|
36-3898269
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification
No.)
|
810
Seventh Avenue, 4th Floor
New
York, New York 10019
(Address
of principal executive offices) (Zip Code)
(212)
582-3950
(Registrant's
telephone number, including area code)
Not
applicable
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Item
5.02
Departure
of Directors or Certain Officers; Election of Directors: Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers
On
December 27, 2007, Manhattan Pharmaceuticals, Inc. (the “Company”) announced
that Dr. Alan Harris, the Company’s Chief Medical Officer, was leaving the
Company.
A
copy of
that announcement is attached to this Form 8-K as exhibit 99.1 hereto.
Item
9.01. Financial Statements and Exhibits
Exhibit
No.
|
|
Description
|
99.1
|
|
Press
Release issued December 27,
2007.
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
MANHATTAN
PHARMACEUTICALS, INC.
|
|
|
|
Date:
January 3, 2008
|
By:
|
/s/ Michael
G. McGuinness
|
|
|
|
Michael
G. McGuinness
|
|
Chief
Financial Officer
|
EXHIBIT
INDEX
Exhibit
No.
|
|
Description
|
99.1
|
|
Press
Release issued December 27, 2007
|
Manhattan Pharmaceuticals (AMEX:MHA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Manhattan Pharmaceuticals (AMEX:MHA)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Manhattan Pharmaceuticals (American Stock Exchange): 0 recent articles
More Manhattan Pharmaceuticals Inc News Articles